nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—ALB—type 1 diabetes mellitus	0.405	1	CbGaD
Acetylsalicylic acid—NFKBIA—nerve—type 1 diabetes mellitus	0.0119	0.08	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—type 1 diabetes mellitus	0.0116	0.0784	CbGeAlD
Acetylsalicylic acid—NFKBIA—islet of Langerhans—type 1 diabetes mellitus	0.00575	0.0388	CbGeAlD
Acetylsalicylic acid—HSPA5—islet of Langerhans—type 1 diabetes mellitus	0.00564	0.038	CbGeAlD
Acetylsalicylic acid—NFKBIA—retina—type 1 diabetes mellitus	0.00492	0.0331	CbGeAlD
Acetylsalicylic acid—HSPA5—retina—type 1 diabetes mellitus	0.00482	0.0325	CbGeAlD
Acetylsalicylic acid—RPS6KA3—islet of Langerhans—type 1 diabetes mellitus	0.0048	0.0323	CbGeAlD
Acetylsalicylic acid—NFKBIA—nephron tubule—type 1 diabetes mellitus	0.00463	0.0312	CbGeAlD
Acetylsalicylic acid—HSPA5—nephron tubule—type 1 diabetes mellitus	0.00454	0.0306	CbGeAlD
Acetylsalicylic acid—TP53—cardiovascular system—type 1 diabetes mellitus	0.00423	0.0285	CbGeAlD
Acetylsalicylic acid—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.00417	0.0964	CcSEcCtD
Acetylsalicylic acid—NFKBIA—cardiovascular system—type 1 diabetes mellitus	0.00416	0.028	CbGeAlD
Acetylsalicylic acid—TP53—kidney—type 1 diabetes mellitus	0.00414	0.0279	CbGeAlD
Acetylsalicylic acid—TP53—pancreas—type 1 diabetes mellitus	0.00411	0.0277	CbGeAlD
Acetylsalicylic acid—RPS6KA3—retina—type 1 diabetes mellitus	0.0041	0.0276	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiovascular system—type 1 diabetes mellitus	0.00408	0.0275	CbGeAlD
Acetylsalicylic acid—NFKBIA—kidney—type 1 diabetes mellitus	0.00407	0.0274	CbGeAlD
Acetylsalicylic acid—NFKBIA—pancreas—type 1 diabetes mellitus	0.00404	0.0272	CbGeAlD
Acetylsalicylic acid—HSPA5—kidney—type 1 diabetes mellitus	0.00399	0.0269	CbGeAlD
Acetylsalicylic acid—HSPA5—pancreas—type 1 diabetes mellitus	0.00396	0.0267	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nephron tubule—type 1 diabetes mellitus	0.00386	0.026	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—type 1 diabetes mellitus	0.00355	0.0239	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—type 1 diabetes mellitus	0.0035	0.0236	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiovascular system—type 1 diabetes mellitus	0.00347	0.0234	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—type 1 diabetes mellitus	0.00343	0.0231	CbGeAlD
Acetylsalicylic acid—RPS6KA3—kidney—type 1 diabetes mellitus	0.0034	0.0229	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pancreas—type 1 diabetes mellitus	0.00337	0.0227	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—type 1 diabetes mellitus	0.00292	0.0197	CbGeAlD
Acetylsalicylic acid—SLC22A6—nephron tubule—type 1 diabetes mellitus	0.00267	0.018	CbGeAlD
Acetylsalicylic acid—IKBKB—cardiovascular system—type 1 diabetes mellitus	0.00256	0.0173	CbGeAlD
Acetylsalicylic acid—SLC22A7—kidney—type 1 diabetes mellitus	0.00243	0.0164	CbGeAlD
Acetylsalicylic acid—IKBKB—lymphoid tissue—type 1 diabetes mellitus	0.00215	0.0145	CbGeAlD
Acetylsalicylic acid—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00212	0.049	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Ramipril—type 1 diabetes mellitus	0.00201	0.0466	CcSEcCtD
Acetylsalicylic acid—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.0018	0.0417	CcSEcCtD
Acetylsalicylic acid—Polyuria—Ramipril—type 1 diabetes mellitus	0.00167	0.0385	CcSEcCtD
Acetylsalicylic acid—Deafness—Ramipril—type 1 diabetes mellitus	0.00163	0.0378	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00163	0.0378	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Ramipril—type 1 diabetes mellitus	0.00154	0.0355	CcSEcCtD
Acetylsalicylic acid—Purpura—Ramipril—type 1 diabetes mellitus	0.00152	0.0351	CcSEcCtD
Acetylsalicylic acid—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.0015	0.0347	CcSEcCtD
Acetylsalicylic acid—Influenza—Ramipril—type 1 diabetes mellitus	0.00126	0.0292	CcSEcCtD
Acetylsalicylic acid—Asthma—Ramipril—type 1 diabetes mellitus	0.00126	0.0292	CcSEcCtD
Acetylsalicylic acid—PTGS2—islet of Langerhans—type 1 diabetes mellitus	0.00113	0.00759	CbGeAlD
Acetylsalicylic acid—Sweating—Ramipril—type 1 diabetes mellitus	0.00108	0.025	CcSEcCtD
Acetylsalicylic acid—CYP2C8—kidney—type 1 diabetes mellitus	0.00103	0.00693	CbGeAlD
Acetylsalicylic acid—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000943	0.0218	CcSEcCtD
Acetylsalicylic acid—Flushing—Ramipril—type 1 diabetes mellitus	0.000939	0.0217	CcSEcCtD
Acetylsalicylic acid—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000934	0.00629	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.000853	0.00574	CbGeAlD
Acetylsalicylic acid—PTGS1—kidney—type 1 diabetes mellitus	0.000834	0.00562	CbGeAlD
Acetylsalicylic acid—PTGS2—cardiovascular system—type 1 diabetes mellitus	0.000815	0.00549	CbGeAlD
Acetylsalicylic acid—Agitation—Ramipril—type 1 diabetes mellitus	0.000809	0.0187	CcSEcCtD
Acetylsalicylic acid—Angioedema—Ramipril—type 1 diabetes mellitus	0.000805	0.0186	CcSEcCtD
Acetylsalicylic acid—PTGS2—kidney—type 1 diabetes mellitus	0.000797	0.00537	CbGeAlD
Acetylsalicylic acid—PTGS2—pancreas—type 1 diabetes mellitus	0.000792	0.00534	CbGeAlD
Acetylsalicylic acid—Vertigo—Ramipril—type 1 diabetes mellitus	0.000791	0.0183	CcSEcCtD
Acetylsalicylic acid—Syncope—Ramipril—type 1 diabetes mellitus	0.00079	0.0183	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000788	0.0182	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000774	0.0179	CcSEcCtD
Acetylsalicylic acid—Convulsion—Ramipril—type 1 diabetes mellitus	0.000763	0.0177	CcSEcCtD
Acetylsalicylic acid—Chest pain—Ramipril—type 1 diabetes mellitus	0.00075	0.0173	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00075	0.0173	CcSEcCtD
Acetylsalicylic acid—Confusional state—Ramipril—type 1 diabetes mellitus	0.000725	0.0168	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000719	0.0166	CcSEcCtD
Acetylsalicylic acid—Shock—Ramipril—type 1 diabetes mellitus	0.000707	0.0164	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000704	0.0163	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000701	0.0162	CcSEcCtD
Acetylsalicylic acid—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000697	0.00469	CbGeAlD
Acetylsalicylic acid—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000695	0.0161	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymphoid tissue—type 1 diabetes mellitus	0.000685	0.00461	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000641	0.0148	CcSEcCtD
Acetylsalicylic acid—Somnolence—Ramipril—type 1 diabetes mellitus	0.000639	0.0148	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000633	0.0146	CcSEcCtD
Acetylsalicylic acid—ABCB1—retina—type 1 diabetes mellitus	0.000596	0.00401	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000592	0.0137	CcSEcCtD
Acetylsalicylic acid—Urticaria—Ramipril—type 1 diabetes mellitus	0.000571	0.0132	CcSEcCtD
Acetylsalicylic acid—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000561	0.00378	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000529	0.0123	CcSEcCtD
Acetylsalicylic acid—Pruritus—Ramipril—type 1 diabetes mellitus	0.000508	0.0118	CcSEcCtD
Acetylsalicylic acid—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000504	0.0034	CbGeAlD
Acetylsalicylic acid—ABCB1—kidney—type 1 diabetes mellitus	0.000493	0.00332	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000492	0.0114	CcSEcCtD
Acetylsalicylic acid—ABCB1—pancreas—type 1 diabetes mellitus	0.00049	0.0033	CbGeAlD
Acetylsalicylic acid—Dizziness—Ramipril—type 1 diabetes mellitus	0.000475	0.011	CcSEcCtD
Acetylsalicylic acid—Vomiting—Ramipril—type 1 diabetes mellitus	0.000457	0.0106	CcSEcCtD
Acetylsalicylic acid—Rash—Ramipril—type 1 diabetes mellitus	0.000453	0.0105	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000453	0.0105	CcSEcCtD
Acetylsalicylic acid—Nausea—Ramipril—type 1 diabetes mellitus	0.000427	0.00988	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000424	0.00285	CbGeAlD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.79e-05	6.92e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—type 1 diabetes mellitus	2.77e-05	6.87e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IFNG—type 1 diabetes mellitus	2.76e-05	6.85e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—type 1 diabetes mellitus	2.76e-05	6.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	2.75e-05	6.83e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.75e-05	6.81e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.75e-05	6.81e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL2—type 1 diabetes mellitus	2.75e-05	6.81e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—VAV1—type 1 diabetes mellitus	2.73e-05	6.77e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.71e-05	6.71e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.71e-05	6.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	2.69e-05	6.68e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.69e-05	6.66e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.69e-05	6.66e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CD4—type 1 diabetes mellitus	2.67e-05	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.66e-05	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—STAT3—type 1 diabetes mellitus	2.66e-05	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQA1—type 1 diabetes mellitus	2.64e-05	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	2.63e-05	6.52e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.62e-05	6.48e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.58e-05	6.4e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ITPR3—type 1 diabetes mellitus	2.54e-05	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.54e-05	6.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	2.53e-05	6.28e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CD80—type 1 diabetes mellitus	2.53e-05	6.27e-05	CbGpPWpGaD
Acetylsalicylic acid—SLC22A6—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	2.53e-05	6.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	2.52e-05	6.25e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—TYK2—type 1 diabetes mellitus	2.52e-05	6.24e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CD80—type 1 diabetes mellitus	2.5e-05	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	2.49e-05	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—type 1 diabetes mellitus	2.48e-05	6.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DQB1—type 1 diabetes mellitus	2.47e-05	6.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	2.47e-05	6.13e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—type 1 diabetes mellitus	2.46e-05	6.11e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	2.46e-05	6.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	2.46e-05	6.09e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2—type 1 diabetes mellitus	2.45e-05	6.09e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	2.45e-05	6.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.43e-05	6.02e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—type 1 diabetes mellitus	2.42e-05	6e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	2.41e-05	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.41e-05	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.41e-05	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	2.41e-05	5.97e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HBA1—type 1 diabetes mellitus	2.39e-05	5.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	2.39e-05	5.92e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—INS—type 1 diabetes mellitus	2.39e-05	5.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	2.39e-05	5.92e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD86—type 1 diabetes mellitus	2.38e-05	5.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOC3—type 1 diabetes mellitus	2.38e-05	5.89e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—INS—type 1 diabetes mellitus	2.36e-05	5.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	2.35e-05	5.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD40LG—type 1 diabetes mellitus	2.34e-05	5.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTT1—type 1 diabetes mellitus	2.33e-05	5.79e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—STAT3—type 1 diabetes mellitus	2.31e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD8A—type 1 diabetes mellitus	2.31e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.31e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	2.31e-05	5.72e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.28e-05	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CD4—type 1 diabetes mellitus	2.28e-05	5.65e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CD80—type 1 diabetes mellitus	2.26e-05	5.6e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CD80—type 1 diabetes mellitus	2.26e-05	5.6e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOC3—type 1 diabetes mellitus	2.25e-05	5.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IAPP—type 1 diabetes mellitus	2.25e-05	5.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-B—type 1 diabetes mellitus	2.22e-05	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.22e-05	5.51e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.22e-05	5.5e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	2.2e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	2.19e-05	5.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—CD4—type 1 diabetes mellitus	2.19e-05	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—B2M—type 1 diabetes mellitus	2.16e-05	5.36e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—type 1 diabetes mellitus	2.16e-05	5.35e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.15e-05	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB3—type 1 diabetes mellitus	2.15e-05	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	2.14e-05	5.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—INS—type 1 diabetes mellitus	2.13e-05	5.29e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—INS—type 1 diabetes mellitus	2.13e-05	5.29e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.13e-05	5.29e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SST—type 1 diabetes mellitus	2.12e-05	5.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.11e-05	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.11e-05	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—type 1 diabetes mellitus	2.1e-05	5.21e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	2.1e-05	5.2e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.09e-05	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2RA—type 1 diabetes mellitus	2.08e-05	5.16e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.07e-05	5.13e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—STAT3—type 1 diabetes mellitus	2.07e-05	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.06e-05	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.06e-05	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-A—type 1 diabetes mellitus	2.06e-05	5.1e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.05e-05	5.09e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.05e-05	5.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	2.02e-05	5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	2e-05	4.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CRP—type 1 diabetes mellitus	1.96e-05	4.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	1.94e-05	4.82e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	1.93e-05	4.79e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.91e-05	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.91e-05	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	1.9e-05	4.71e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GCG—type 1 diabetes mellitus	1.89e-05	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	1.89e-05	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HLA-DRB1—type 1 diabetes mellitus	1.88e-05	4.66e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—type 1 diabetes mellitus	1.88e-05	4.65e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.87e-05	4.64e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.87e-05	4.64e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.87e-05	4.63e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—type 1 diabetes mellitus	1.86e-05	4.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GCG—type 1 diabetes mellitus	1.86e-05	4.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	1.85e-05	4.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.82e-05	4.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS1—type 1 diabetes mellitus	1.81e-05	4.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	1.81e-05	4.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	1.8e-05	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.78e-05	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2—type 1 diabetes mellitus	1.78e-05	4.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.77e-05	4.38e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.76e-05	4.37e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.76e-05	4.36e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2—type 1 diabetes mellitus	1.75e-05	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD80—type 1 diabetes mellitus	1.74e-05	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	1.74e-05	4.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	1.71e-05	4.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.71e-05	4.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	1.7e-05	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.7e-05	4.2e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.69e-05	4.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—VAV1—type 1 diabetes mellitus	1.65e-05	4.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	1.64e-05	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	1.63e-05	4.04e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—type 1 diabetes mellitus	1.61e-05	4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—type 1 diabetes mellitus	1.6e-05	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	1.6e-05	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.6e-05	3.96e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.59e-05	3.94e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.59e-05	3.94e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.59e-05	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—type 1 diabetes mellitus	1.59e-05	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	1.58e-05	3.92e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.58e-05	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.58e-05	3.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CAT—type 1 diabetes mellitus	1.57e-05	3.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	1.54e-05	3.83e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD86—type 1 diabetes mellitus	1.54e-05	3.82e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—type 1 diabetes mellitus	1.54e-05	3.82e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HBA1—type 1 diabetes mellitus	1.54e-05	3.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	1.53e-05	3.8e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOC3—type 1 diabetes mellitus	1.53e-05	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	1.51e-05	3.74e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	1.5e-05	3.72e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.49e-05	3.7e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.48e-05	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	1.48e-05	3.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—TYK2—type 1 diabetes mellitus	1.47e-05	3.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	1.46e-05	3.63e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.46e-05	3.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	1.45e-05	3.6e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—type 1 diabetes mellitus	1.44e-05	3.58e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD86—type 1 diabetes mellitus	1.44e-05	3.56e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.43e-05	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.39e-05	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.39e-05	3.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	1.38e-05	3.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IFNG—type 1 diabetes mellitus	1.37e-05	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	1.37e-05	3.4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.37e-05	3.39e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.36e-05	3.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.35e-05	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.35e-05	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	1.35e-05	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.34e-05	3.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.34e-05	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.34e-05	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.34e-05	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.34e-05	3.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CD4—type 1 diabetes mellitus	1.33e-05	3.29e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.31e-05	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.3e-05	3.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	1.3e-05	3.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CCR5—type 1 diabetes mellitus	1.27e-05	3.16e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.26e-05	3.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	1.25e-05	3.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.25e-05	3.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	1.24e-05	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.24e-05	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—type 1 diabetes mellitus	1.23e-05	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—type 1 diabetes mellitus	1.23e-05	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.23e-05	3.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—type 1 diabetes mellitus	1.23e-05	3.04e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—type 1 diabetes mellitus	1.22e-05	3.03e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.21e-05	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.21e-05	3.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	1.2e-05	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GCG—type 1 diabetes mellitus	1.19e-05	2.96e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.15e-05	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.13e-05	2.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CD80—type 1 diabetes mellitus	1.12e-05	2.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS2—type 1 diabetes mellitus	1.08e-05	2.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	1.07e-05	2.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—INS—type 1 diabetes mellitus	1.06e-05	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD80—type 1 diabetes mellitus	1.05e-05	2.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.05e-05	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—INS—type 1 diabetes mellitus	1.04e-05	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—type 1 diabetes mellitus	1.04e-05	2.59e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—type 1 diabetes mellitus	1.03e-05	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—type 1 diabetes mellitus	1.03e-05	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.03e-05	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	1.02e-05	2.52e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.01e-05	2.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—INS—type 1 diabetes mellitus	9.9e-06	2.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	9.77e-06	2.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	9.58e-06	2.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TYK2—type 1 diabetes mellitus	9.48e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—type 1 diabetes mellitus	9.34e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—type 1 diabetes mellitus	9.33e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—type 1 diabetes mellitus	9.33e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.31e-06	2.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	9.16e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	9.07e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	8.86e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TYK2—type 1 diabetes mellitus	8.85e-06	2.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NOS3—type 1 diabetes mellitus	8.68e-06	2.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—INS—type 1 diabetes mellitus	8.29e-06	2.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	8.27e-06	2.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CD4—type 1 diabetes mellitus	8e-06	1.98e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.9e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—type 1 diabetes mellitus	7.89e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	7.6e-06	1.89e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	7.27e-06	1.8e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—type 1 diabetes mellitus	7.17e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	6.75e-06	1.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—INS—type 1 diabetes mellitus	6.71e-06	1.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.64e-06	1.65e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—type 1 diabetes mellitus	6.19e-06	1.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	6.19e-06	1.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.04e-06	1.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	6.02e-06	1.49e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	5.92e-06	1.47e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NOS3—type 1 diabetes mellitus	5.88e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—INS—type 1 diabetes mellitus	5.88e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—type 1 diabetes mellitus	5.63e-06	1.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	5.52e-06	1.37e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	5.49e-06	1.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	5.39e-06	1.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	5.28e-06	1.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	5.16e-06	1.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.03e-06	1.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	4.82e-06	1.19e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—type 1 diabetes mellitus	4.64e-06	1.15e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—type 1 diabetes mellitus	4.33e-06	1.07e-05	CbGpPWpGaD
